Learn more about the observational retrospective cohort study that found approximately only 1 in 5 patients with a definitive cardiac implanted device infection received complete hardware removal with extraction.
There are a lot of studies that have been published that focus on treatment for device infection in single centers or in single health systems. But there are very few analyses that look at the management of cardiac and planet electronic device infections across an entire country. And so we conducted this nationwide analysis of management of device infections to try and understand how patients in clinical practice are being treated and to what extent they are benefiting from the full consensus and guideline recommendations for the treatment of cardiac implant device infections, including not only antibiotic therapy but importantly, complete hardware removal to eradicate the infection and lead to a cure. We had some hypotheses when we started this observation or retrospective cohort study, um, but we could have never guessed the results. And what I mean by that is we thought for sure that some patients didn't have access to or did not receive extraction. But we were really blown away to see that approximately only one in five patients with a definitive cardiac implant electronic device infection received complete hardware removal with extraction. I don't think any of the investigators would have predicted that. But that's what the data indicated in a very robust and reproducible fashion
